GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 45 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,451,000 | -76.5% | 547,488 | -41.1% | 0.07% | -76.1% |
| Q2 2020 | $6,169,000 | +14.1% | 929,022 | 0.0% | 0.28% | -19.7% |
| Q1 2020 | $5,407,000 | -35.1% | 929,022 | 0.0% | 0.36% | -29.6% |
| Q4 2019 | $8,333,000 | +3.9% | 929,022 | 0.0% | 0.50% | +109.1% |
| Q3 2019 | $8,022,000 | -22.5% | 929,022 | 0.0% | 0.24% | +23.0% |
| Q2 2019 | $10,349,000 | -16.2% | 929,022 | 0.0% | 0.20% | -69.3% |
| Q1 2019 | $12,356,000 | -13.9% | 929,022 | 0.0% | 0.64% | -62.4% |
| Q4 2018 | $14,353,000 | +8.5% | 929,022 | 0.0% | 1.70% | +33.9% |
| Q3 2018 | $13,229,000 | – | 929,022 | – | 1.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |